{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:28:12Z","timestamp":1760783292222,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.arcmed.2010.05.009","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T05:16:25Z","timestamp":1279170985000},"page":"297-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is Dysfunction of Caveolin-1 a Link Between Systemic Sclerosis and Breast Cancer, Opening a Window on Both Etiologies?"],"prefix":"10.1016","volume":"41","author":[{"given":"Niansong","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2010.05.009_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2010.05.009_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/ard.2006.056424","article-title":"Risk factors for lung cancer in patients with scleroderma: a nested case-control study","volume":"66","author":"Pontifex","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2010.05.009_bib3","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10067-007-0546-9","article-title":"Associations of breast cancer development in patients with systemic sclerosis: an exploratory study","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr1831","article-title":"Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence","volume":"10","author":"Martin","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.arcmed.2010.05.009_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/ar2825","article-title":"Why are women predisposed to autoimmune rheumatic diseases?","volume":"11","author":"Oliver","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arcmed.2010.05.009_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2585","article-title":"What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases","volume":"11","author":"Oliver","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"159","key":"10.1016\/j.arcmed.2010.05.009_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/aje\/kwh027","article-title":"Childbearing and the risk of scleroderma: a population-based study in Sweden","volume":"15","author":"Lambe","year":"2004","journal-title":"Am J Epideimol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ard.61.4.346","article-title":"Influence of prior pregnancies on disease course and cause of death in systemic sclerosis","volume":"61","author":"Artlett","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2010.05.009_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/djq146","article-title":"Mimicking pregnancy to reduce breast cancer risk","volume":"21","author":"Tuma","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2010.05.009_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00002281-200011000-00007","article-title":"Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon","volume":"12","author":"Tan","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1529-0131(200104)44:4<893::AID-ANR146>3.0.CO;2-3","article-title":"Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations","volume":"44","author":"Tan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2010.05.009_bib13","first-page":"914","article-title":"Estrogen receptor gene polymorphisms in Japanese patients with systemic sclerosis","volume":"26","author":"Hoshi","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib14","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1074\/jbc.M412551200","article-title":"Opposing effects of protein kinase C alpha and protein kinase C epsilon on collagen expression by human lung fibroblasts are mediated via MEK\/ERK and caveolin-1 signaling","volume":"280","author":"Tourkina","year":"2005","journal-title":"J Biol Chem"},{"issue":"293","key":"10.1016\/j.arcmed.2010.05.009_bib15","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice","volume":"28","author":"Drab","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2010.05.009_bib16","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.M105408200","article-title":"Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities","volume":"12","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2010.05.009_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1369\/jhc.7A7203.2007","article-title":"Loss of caveolin-1 in bronchiolization in lung fibrosis","volume":"55","author":"Odajima","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.arcmed.2010.05.009_bib18","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Galdo","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3729","key":"10.1016\/j.arcmed.2010.05.009_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"25","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2010.05.009_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-004-2229-4","article-title":"Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments","volume":"89","author":"Achiron","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2010.05.009_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2005.03.019","article-title":"Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis","volume":"165","author":"Shin","year":"2005","journal-title":"J Neuroimmunol"},{"issue":"150B","key":"10.1016\/j.arcmed.2010.05.009_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajmg.b.30805","article-title":"A novel polymorphic purine complex at the 1.5 kb upstream region of the human caveolin-1 gene and risk of Alzheimer's disease; extra-short alleles and accumulated allele homozygosity","volume":"5","author":"Heshmati","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"153B","key":"10.1016\/j.arcmed.2010.05.009_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.b.30985","article-title":"Novel extreme homozygote haplotypes at the human caveolin 1 gene upstream purine complex in sporadic Alzheimer's disease","volume":"5","author":"Zarif Yeganeh","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"216","key":"10.1016\/j.arcmed.2010.05.009_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jneuroim.2009.09.007","article-title":"Skew in the human caveolin 1 gene upstream purine complex homozygote haplotype compartment in multiple sclerosis","volume":"30","author":"Zarif Yeganeh","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"66","key":"10.1016\/j.arcmed.2010.05.009_bib26","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1158\/0008-5472.CAN-06-2805","article-title":"Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers","volume":"15","author":"Sotgia","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2010.05.009_bib27","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","article-title":"Cyclin D1: normal and abnormal functions","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2010.05.009_bib28","doi-asserted-by":"crossref","first-page":"20717","DOI":"10.1074\/jbc.M909895199","article-title":"Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2010.05.009_bib29","doi-asserted-by":"crossref","first-page":"51630","DOI":"10.1074\/jbc.M409214200","article-title":"Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo: role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2\/9) secretion","volume":"279","author":"Williams","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2010.05.009_bib30","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers","volume":"174","author":"Witkiewicz","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4161\/cbt.8.11.8874","article-title":"Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer","volume":"8","author":"Witkiewicz","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.arcmed.2010.05.009_bib32","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2353\/ajpath.2006.060590","article-title":"Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells","volume":"169","author":"Williams","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4161\/cbt.5.3.2390","article-title":"Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling","volume":"5","author":"Sotgia","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.arcmed.2010.05.009_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-008-9156-4","article-title":"The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression","volume":"25","author":"Vincan","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.arcmed.2010.05.009_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/01902140903042589","article-title":"Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1","volume":"36","author":"Yamauchi","year":"2010","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.arcmed.2010.05.009_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2353\/ajpath.2006.050429","article-title":"Caveolin-1 deficiency (-\/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness","volume":"168","author":"Sotgia","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000184792","article-title":"Transforming growth factors-beta s: a multifunctional cytokine family. Implication in the regulation of adrenocortical cell endocrine functions","volume":"45","author":"Chambaz","year":"1996","journal-title":"Horm Res"},{"key":"10.1016\/j.arcmed.2010.05.009_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massagu\u00e9","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2010.05.009_bib40","first-page":"235","article-title":"Mechanism and function of signaling by the TGF beta superfamily","volume":"228","author":"Hoodless","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"issue":"87","key":"10.1016\/j.arcmed.2010.05.009_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0092-8674(00)81817-6","article-title":"MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling","volume":"27","author":"Mac\u00edas-Silva","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2010.05.009_bib42","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","article-title":"Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signaling through an interaction with the TGF-beta type I receptor","volume":"276","author":"Razani","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2010.05.009_bib43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.106.634709","article-title":"Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"114","author":"Jasmin","year":"2006","journal-title":"Circulation"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440910001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440910001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:37:59Z","timestamp":1759261079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440910001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0188440910001359"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2010.05.009","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Dysfunction of Caveolin-1 a Link Between Systemic Sclerosis and Breast Cancer, Opening a Window on Both Etiologies?","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2010.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}